34 Healthcare Stocks Moving In Wednesday's Pre-Market Session

Gainers

• OrganiGram Holdings, Inc. OGI shares increased by 26.9% to $2.74 during Wednesday's pre-market session. According to the most recent rating by Raymond James, on January 09, the current rating is at Market Perform.
• Rockwell Medical, Inc. RMTI stock rose 23.3% to $2.86. The most recent rating by Piper Jaffray, on November 12, is at Overweight, with a price target of $6.00.
• Oncolytics Biotech, Inc. ONCY stock increased by 16.7% to $3.35.
• Clovis Oncology, Inc. CLVS stock moved upwards by 15.6% to $10.29. The most recent rating by Evercore ISI Group, on November 19, is at In-Line, with a price target of $8.00.
• Momenta Pharmaceuticals, Inc. MNTA stock moved upwards by 14.8% to $29.12. The most recent rating by JP Morgan, on January 15, is at Overweight, with a price target of $30.00.
• Durect, Inc. DRRX stock increased by 13.4% to $2.79. The most recent rating by Cantor Fitzgerald, on November 18, is at Overweight, with a price target of $5.00.
• Neovasc, Inc. NVCN shares increased by 13.3% to $3.50. The most recent rating by H.C. Wainwright, on October 24, is at Buy, with a price target of $9.00.
• Beyond Air, Inc. XAIR shares surged 8.8% to $6.30. The most recent rating by Oppenheimer, on October 22, is at Outperform, with a price target of $9.00.
• TRACON Pharmaceuticals, Inc. TCON shares increased by 7.1% to $3.00. The most recent rating by H.C. Wainwright, on December 23, is at Buy, with a price target of $18.00.
• Tilray, Inc. TLRY shares surged 5.4% to $22.36. The most recent rating by B of A Securities, on January 13, is at Neutral, with a price target of $18.00.
• ASLAN Pharmaceuticals, Inc. ASLN shares increased by 5.2% to $2.61. The most recent rating by H.C. Wainwright, on December 10, is at Buy, with a price target of $5.00.
• OpGen, Inc. OPGN stock surged 4.3% to $1.69.
• Titan Pharmaceuticals, Inc. TTNP stock rose 4.2% to $0.28. The most recent rating by Maxim Group, on October 23, is at Buy, with a price target of $1.00.
• HEXO, Inc. HEXO shares surged 3.8% to $1.65.
• Aurora Cannabis, Inc. ACB shares moved upwards by 3.6% to $1.85. The most recent rating by Piper Sandler, on January 10, is at Underweight, with a price target of $1.00.
• Sorrento Therapeutics, Inc. SRNE stock moved upwards by 3.2% to $4.24.
• Aphria, Inc. APHA shares moved upwards by 3.0% to $5.13. According to the most recent rating by B of A Securities, on January 13, the current rating is at Neutral.
• ContraFect, Inc. CFRX stock rose 2.5% to $1.26.
• Microbot Medical, Inc. MBOT stock surged 2.2% to $11.85. The most recent rating by H.C. Wainwright, on January 13, is at Buy, with a price target of $26.00.
• CannTrust Holdings, Inc. CTST stock rose 1.8% to $1.13.
• Acorda Therapeutics, Inc. ACOR shares rose 1.7% to $2.38. According to the most recent rating by JP Morgan, on October 24, the current rating is at Underweight.
• Canopy Growth, Inc. CGC stock surged 1.7% to $24.25. According to the most recent rating by Bank of America, on November 20, the current rating is at Buy.
• Novo Nordisk, Inc. NVO stock rose 1.7% to $60.61. The most recent rating by Ladenburg Thalmann, on January 06, is at Buy, with a price target of $15.00.

Losers

• Accelerate Diagnostics, Inc. AXDX shares plummeted 15.8% to $15.25 during Wednesday's pre-market session.
• Nektar Therapeutics, Inc. NKTR stock plummeted 14.7% to $23.84. The most recent rating by JP Morgan, on November 13, is at Neutral, with a price target of $28.00.
• Midatech Pharma, Inc. MTP stock decreased by 10.0% to $0.90.
• Adaptimmune Therapeutics, Inc. ADAP shares plummeted 5.9% to $3.80.
• Acasti Pharma, Inc. ACST shares fell 4.3% to $0.90. The most recent rating by B. Riley FBR, on January 13, is at Neutral, with a price target of $2.00.
• Genetic Technologies, Inc. GENE stock decreased by 3.9% to $4.23.
• La Jolla Pharmaceutical, Inc. LJPC shares plummeted 3.6% to $8.52. According to the most recent rating by H.C. Wainwright, on November 26, the current rating is at Neutral.
• Cyclerion Therapeutics, Inc. CYCN shares fell 2.7% to $3.60.
• Cassava Sciences, Inc. SAVA stock decreased by 2.1% to $7.36. The most recent rating by H.C. Wainwright, on December 06, is at Buy, with a price target of $6.00.
• Dare Bioscience, Inc. DARE stock plummeted 1.5% to $1.35.
• UnitedHealth Group, Inc. UNH stock plummeted 1.2% to $284.50. The most recent rating by Credit Suisse, on January 08, is at Outperform, with a price target of $330.00.